Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study.
about
The intersection of attention-deficit/hyperactivity disorder and substance abuseEfficacy of psychostimulant drugs for amphetamine abuse or dependenceAre there any potentially dangerous pharmacological effects of combining ADHD medication with alcohol and drugs of abuse? A systematic review of the literatureAgonist replacement for stimulant dependence: a review of clinical researchEfficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adultsPharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us?Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study.An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adultsMethylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trialInvestigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial.Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial.Effects of 7-day continuous D-amphetamine, methylphenidate, and cocaine treatment on choice between methamphetamine and food in male rhesus monkeys.Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysisSubstance-use disorders in adolescents and adults with ADHD: focus on treatment.OROS methylphenidate hydrochloride for adult patients with attention deficit/hyperactivity disorder.Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-deficit/hyperactivity disorder and addiction.Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence.Attention deficit hyperactivity disorder and substance misuse: an evaluation of causal hypotheses and treatment considerations.Managing attention deficit hyperactivity disorder in adults using illicit psychostimulants: A systematic review.A network meta-analysis of atomoxetine and osmotic release oral system methylphenidate in the treatment of attention-deficit/hyperactivity disorder in adult patients.Ling et al.'s 'Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder'.Addiction in developmental perspective: influence of conduct disorder severity, subtype, and attention-deficit hyperactivity disorder on problem severity and comorbidity in adults with opioid dependence.Stimulant medication for ADHD in opioid maintenance treatment.Prevalence of comorbid substance use disorder during long-term central stimulant treatment in adult ADHD.Adolescent d-amphetamine treatment in a rodent model of attention deficit/hyperactivity disorder: impact on cocaine abuse vulnerability in adulthood.
P2860
Q22242685-47F2BB44-3C2C-49A7-8E99-F2A2669B7078Q24198261-DBC42131-F3B7-483B-B000-1A7F98CC97BFQ26777710-DF682176-447F-4FDF-B706-FD4FC2243C77Q27014854-30A24D10-9CBB-49BB-B8E5-FA4BAFA799C0Q28246506-C494988D-5F80-4911-B030-5EB8B265C052Q33919950-544A382C-4C5A-4D78-8DC3-E151A750C781Q33957119-E5E9FA26-D95D-4CAA-856D-819A3C5F6B63Q34220004-7FE91EEC-2165-4F64-ADBD-1022E08AB735Q34481951-04915169-A8FF-4F4E-8690-C0D317AA1790Q34714758-9407D7E5-871A-4BF7-971D-AE9292421E17Q34981228-727AE6B7-0347-4AE7-8868-B545FE877064Q36090475-004B38A4-DE49-4BEE-9F77-538873D52E2CQ36192104-11F08C6F-7809-4D73-8348-7EBB8BC2703CQ36344412-8E89DAA2-B786-49A1-9050-A655DD7B1EF2Q37827879-14DF2206-538D-44D9-BE79-7EDC3E0C16E0Q38065287-7445BF96-1D92-4347-91A4-FEE03E3C3378Q38241724-A9895DEB-4E43-4C2C-8C79-0E00D2E20A71Q38569727-5AE76366-12A2-4DAD-96E3-E317AC8D16D1Q38714397-E0AB2E9F-A529-4D01-B55E-640E3EBB4B47Q38785464-98A15BB7-A03A-4AE7-B5BD-B3789D3654ECQ42358768-F15C0786-11E1-47C8-AD84-9D872BB35129Q44333067-9752525F-AC89-498B-8520-27141E30149DQ44348151-5FCFF6A6-B0C7-44E5-A5FE-E2DB6B3840CBQ44973697-5DD00165-E779-439F-AF7C-9ACE60F1B6C9Q48527671-218D8F38-469E-484C-BE5C-E75B8829C401
P2860
Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Sustained release methylphenid ...... tamine abusers: a pilot study.
@en
Sustained release methylphenid ...... tamine abusers: a pilot study.
@nl
type
label
Sustained release methylphenid ...... tamine abusers: a pilot study.
@en
Sustained release methylphenid ...... tamine abusers: a pilot study.
@nl
prefLabel
Sustained release methylphenid ...... tamine abusers: a pilot study.
@en
Sustained release methylphenid ...... tamine abusers: a pilot study.
@nl
P2093
P1476
Sustained release methylphenid ...... tamine abusers: a pilot study.
@en
P2093
Johan Franck
Maija Konstenius
Nitya Jayaram-Lindström
P304
P356
10.1016/J.DRUGALCDEP.2009.11.006
P50
P577
2009-12-16T00:00:00Z